These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5924575)

  • 41. The diagnosis and treatment of toxoplasmosis.
    McCabe RE; Remington JS
    Eur J Clin Microbiol; 1983 Apr; 2(2):95-104. PubMed ID: 6861739
    [No Abstract]   [Full Text] [Related]  

  • 42. Toxoplasmosis in AIDS patients.
    Tuazon CU
    J Antimicrob Chemother; 1989 Jan; 23 Suppl A():77-82. PubMed ID: 2654118
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chemotherapy of toxoplasmic encephalitis in AIDS patients.
    Filice G; Carnevale G; Orsolini P; Soldini L; Meroni V; Comolli G; Carenzo L
    J Chemother; 1989 Jul; 1(4 Suppl):949-50. PubMed ID: 16312718
    [No Abstract]   [Full Text] [Related]  

  • 44. Prospective, randomized trial of trimethoprim/sulfamethoxazole vs. pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis: discussion.
    Holland GN
    Ophthalmology; 2005 Nov; 112(11):1882-4. PubMed ID: 16271316
    [No Abstract]   [Full Text] [Related]  

  • 45. Alternative treatment approach to cerebral toxoplasmosis in HIV/AIDS: experience from a resource-poor setting.
    Goswami RP; Goswami RP; Rahman M; Ray Y; Tripathi SK
    Int J STD AIDS; 2015 Oct; 26(12):864-9. PubMed ID: 25411350
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Acute myocarditis caused by toxoplasmosis simulating infarction. Apropos of a case].
    Lesenne M; Asseman P; Fortier B; de Groote P; Bauchart JJ; Millaire A; Haftel Y; Thery C
    Arch Mal Coeur Vaiss; 1996 Jul; 89(7):923-5. PubMed ID: 8869256
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cerebral toxoplasmosis in the acquired immune deficiency syndrome.
    Carrazana EJ; Rossitch E; Samuels MA
    Clin Neurol Neurosurg; 1989; 91(4):291-301. PubMed ID: 2555089
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adult toxoplasmosis presenting as polymyositis and cerebellar ataxia.
    Greenlee JE; Johnson WD; campa JF; Adelman LS; Sande MA
    Ann Intern Med; 1975 Mar; 82(3):367-71. PubMed ID: 1078759
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil.
    Silva LA; Fernandes MD; Machado AS; Reis-Cunha JL; Bartholomeu DC; Almeida Vitor RW
    Exp Parasitol; 2019 Jul; 202():7-14. PubMed ID: 31077733
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A case of toxoplasmosic chronic myocarditis].
    NIEDMANN G; THIERMANN E; DEL CAMPO E
    Bol Chil Parasitol; 1959; 14():59-61. PubMed ID: 14427066
    [No Abstract]   [Full Text] [Related]  

  • 51. Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model.
    Martins-Duarte ÉS; de Souza W; Vommaro RC
    Exp Parasitol; 2013 Mar; 133(3):294-9. PubMed ID: 23270807
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemotherapy in experimental toxoplasmosis: comparison of the efficacy of trimethoprim-sulfur and pyrimethamine-sulfur combinations.
    Seah SK
    J Trop Med Hyg; 1975 Jul; 78(7):150-3. PubMed ID: 1177347
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Myocardial toxoplasmosis.
    PAULLEY JW; GREEN WP; JONES R; KANE EP
    Lancet; 1954 Sep; 267(6839):624-6. PubMed ID: 13202454
    [No Abstract]   [Full Text] [Related]  

  • 54. THE DIAGNOSIS OF ADULT TOXOPLASMOSIS.
    LAKE B
    Med J Aust; 1963 Aug; 2():269-71. PubMed ID: 14048425
    [No Abstract]   [Full Text] [Related]  

  • 55. The development of polymyositis in a patient with toxoplasmosis: clinical and pathologic findings and review of literature.
    Adams EM; Hafez GR; Carnes M; Wiesner JK; Graziano FM
    Clin Exp Rheumatol; 1984; 2(3):205-8. PubMed ID: 6529871
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Toxoplasmosis in pregnancy. Diagnosis and new therapeutic possibilities].
    Mirlesse V; Jacquemard F; Daffos F
    Presse Med; 1993 Feb; 22(6):258-62. PubMed ID: 8511144
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sulfadiazine crystalluria revisited. The treatment of Toxoplasma encephalitis in patients with acquired immunodeficiency syndrome.
    Simon DI; Brosius FC; Rothstein DM
    Arch Intern Med; 1990 Nov; 150(11):2379-84. PubMed ID: 2241449
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Spanish Toxoplasmosis Study Group.
    Podzamczer D; Miró JM; Ferrer E; Gatell JM; Ramón JM; Ribera E; Sirera G; Cruceta A; Knobel H; Domingo P; Polo R; Leyes M; Cosin J; Fariñas MC; Arrizabalaga J; Martínez-Lacasa J; Gudiol F
    Eur J Clin Microbiol Infect Dis; 2000 Feb; 19(2):89-95. PubMed ID: 10746493
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Simultaneous determination of pyrimethamine, sulfadiazine and N-acetyl-sulfadiazine in plasma for monitoring infants in treatment of congenital toxoplasmosis.
    Johannessen JK; Christiansen I; Schmidt DR; Petersen E; Hansen SH
    J Pharm Biomed Anal; 2005 Jan; 36(5):1093-8. PubMed ID: 15620537
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of infants with congenital toxoplasmosis: tolerability and plasma concentrations of sulfadiazine and pyrimethamine.
    Schmidt DR; Hogh B; Andersen O; Hansen SH; Dalhoff K; Petersen E
    Eur J Pediatr; 2006 Jan; 165(1):19-25. PubMed ID: 16133245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.